Project SEE-SPP – Optimization of treatment flow to improve performance of retinal gene therapy (DFG Schwerpunktprojekt im…

Basic data

Acronym:
SEE-SPP
Title:
Optimization of treatment flow to improve performance of retinal gene therapy (DFG Schwerpunktprojekt im SPP 2127)
Duration:
01/09/2018 to 31/08/2021
Abstract / short description:
Gene therapy of the retina is a novel tool for the treatment of inherited retinal degenerations. Preclinical studies from several groups world-wide including our own clearly show the promise of this approach to provide a cure for this potentially blinding group of diseases. A key, seminal part of the treatment is the subretinal injection. However, there is to our best knowledge no comprehensive data on presumably influential parameters. In this project, we explore options to improve the treatment procedure.
Keywords:
Retinal Gene Therapy, Inherited Retinal Degenerations

Involved staff

Managers

Faculty of Medicine
University of Tübingen
Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Research Center for Ophthalmology
Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Bonn, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.